Detection of Label-Free Drugs within Brain Tissue Using Orbitrap Secondary Ion Mass Spectrometry as a Complement to Neuro-Oncological Drug Delivery
Historically, pre-clinical neuro-oncological drug delivery studies have exhaustively relied upon overall animal survival as an exclusive measure of efficacy. However, with no adopted methodology to both image and quantitate brain parenchyma penetration of label-free drugs, an absence of efficacy typ...
Saved in:
Main Authors: | Phoebe McCrorie (Author), Jonathan Rowlinson (Author), David J. Scurr (Author), Maria Marlow (Author), Ruman Rahman (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Label-free drug discovery
by: Ye eFang
Published: (2014) -
Chemical Analysis and Multi-Component Determination in Chinese Medicine Preparation Bupi Yishen Formula Using Ultra-High Performance Liquid Chromatography With Linear Ion Trap-Orbitrap Mass Spectrometry and Triple-Quadrupole Tandem Mass Spectrometry
by: Jing Zhang, et al.
Published: (2018) -
Epilepsy treatment in neuro-oncology: A rationale for drug choice in common clinical scenarios
by: José Manuel Sánchez-Villalobos, et al.
Published: (2022) -
Psychosocial Advances in Neuro-Oncology
by: Tamara Ownsworth
Published: (2016) -
Update in Pediatric Neuro-Oncology
by: Soumen Khatua (Ed.)
Published: (2019)